Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s41669-019-00188-5
PubMed Identifier: 31777008
Publication URI: http://europepmc.org/abstract/MED/31777008
Type: Journal Article/Review
Volume: 4
Parent Publication: PharmacoEconomics - open
Issue: 3
ISSN: 2509-4262